$17.050
+0.010 (+0.06%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TBPH Prediction & Forecast by Similar Chart Analysis
Alphio's TBPH stock price prediction model matches the current Theravance Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.27 (+1.29%). The 1-week path is $17.53 (+2.80%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Theravance Biopharma Inc Stock?
Theravance Biopharma is currently a hold due to its acquisition by Zymeworks at $17 per share, which reflects a 22% premium, but the stock has shown mixed performance with a recent RSI of 76.26 indicating overbought conditions. The downgrade from analysts and a YTD change of -6.06% suggest caution, despite the potential for future earnings from the acquisition.
TBPH stock price ended at $17.05 on Friday, after rising +0.06%
Theravance Biopharma Inc (TBPH) last closed at $17.05, gaining +0.06%. These facts feed the 1-day and 1-week TBPH price prediction above.
Analyst Consensus
Theravance Biopharma Inc (TBPH): 4 buy, 0 hold, 3 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Theravance Biopharma Inc (TBPH) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TBPH, ranked by similarity.
Seasonality analysis for TBPH
Historically the probability of a positive August return for TBPH is 33.33%. February offers the highest probability of a positive month at 55.17%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TBPH
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $9.17 | $9.56 | $10.36 | -43.92% |
| Sep 2026 | $9.58 | $12.53 | $12.87 | -26.54% |
| Oct 2026 | $11.44 | $12.54 | $12.64 | -26.43% |
| Nov 2026 | $9.84 | $12.93 | $15.45 | -24.15% |
| Dec 2026 | $9.91 | $10.34 | $12.29 | -39.37% |
In 2026, Theravance Biopharma Inc (TBPH) is projected to range from $9.17 to $15.45.
Theravance Biopharma Inc 2026 monthly forecast
In Aug 2026, Theravance Biopharma Inc is projected to average $9.56, with a low of $9.17 and high of $10.36.
In Sep 2026, Theravance Biopharma Inc is projected to average $12.53, with a low of $9.58 and high of $12.87.
In Oct 2026, Theravance Biopharma Inc is projected to average $12.54, with a low of $11.44 and high of $12.64.
In Nov 2026, Theravance Biopharma Inc is projected to average $12.93, with a low of $9.84 and high of $15.45.
In Dec 2026, Theravance Biopharma Inc is projected to average $10.34, with a low of $9.91 and high of $12.29.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.